Quantcast

Latest Early-onset Alzheimer's disease Stories

2010-06-15 14:29:25

By investigating the association between genetic loci related to Alzheimer's disease and neuroimaging measures related to disease risk, researchers may have uncovered additional evidence that several previously studied genetic variants are associated with the development and progression of Alzheimer's disease and also may have identified new genetic risk factors for further study, according to a report in the June issue of Archives of Neurology, one of the JAMA/Archives journals. "The...

2010-06-11 01:45:50

Findings could pave the way for novel treatments Researchers have discovered how mutations in the presenilin 1 gene cause early-onset Alzheimer's disease (AD). The finding, reported online in the journal Cell, opens the door to developing novel treatments for this form of the mind-robbing disease and for the more common, late-onset form that develops later in life and affects millions of people worldwide. The presenilin gene is most commonly associated with the early-onset familial form of...

2010-06-08 11:31:05

Research reveals that a new molecular imaging agent may provide early diagnosis of Alzheimer's disease A multinational clinical trial revealed at SNM's 57th Annual Meeting presents a novel imaging agent that could be the next major breakthrough for the early detection of Alzheimer's disease"”a slow but fatal neurodegenerative disease. The new agent is used in conjunction with a molecular imaging technique called positron emission tomography (PET) and works by binding to beta-amyloid, a...

2010-05-18 11:45:56

APOEe-4 gene carriers with Alzheimer's disease have more memory problems; non-carriers troubled with attention, language and executive function In the most comprehensive study to date, neurologists have clearly identified significant differences in the ways that Alzheimer's disease (AD) affects patients with and without the apolipoprotein E ÃŽµ4 gene (APOE ÃŽµ4), a known genetic risk factor for the neurodegenerative disease, using a combination of cognitive...

2010-05-06 16:10:00

NEW YORK, May 6 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $210,300 to Amicus Therapeutics (Nasdaq: FOLD; Cranbury, NJ) to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer's disease. Amicus has discovered an apparent link between various lysosomal enzymes and accumulation of the beta-amyloid and p-tau deposits observed in the brain of...

2010-03-15 15:40:00

JACKSONVILLE, Fla. "” Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a gene appears to either help protect against development of Alzheimer's disease, or promote the disorder depending on the level of gene in the brain. In two research studies published almost simultaneously in the journals Neurology and PLoS ONE, the scientists found strong evidence for the role of the gene, insulin-degrading enzyme...

990e7b6b2b6bae9ac31555d63bc586c51
2010-03-15 15:37:12

New imaging tool could eventually lead to earlier detection among pre-symptomatic individuals A family history of Alzheimer's is one of the biggest risk factors for developing the memory-robbing disease, which affects more than 5 million Americans and is the most common form of senile dementia. Now an international collaboration led by NYU Langone Medical Center researchers has found the likely basis for this heightened familial risk"”especially from the maternal side. Aided by a new...

2010-02-25 07:05:00

WASHINGTON, Feb. 25 /PRNewswire/ -- Complementary approaches to Alzheimer's research were recognized as four scientists received the prestigious MetLife Foundation Awards for Medical Research in Alzheimer's Disease in Washington, D.C. during a scientific briefing and luncheon. Todd E. Golde, M.D., Ph.D., professor of neuroscience at the University of Florida and director of its Center for Translational Research in Neurodegenerative Diseases, and Edward H. Koo, M.D., professor of...

2010-02-21 08:26:08

Working with worms may not be your average person's idea of a good time, but for University of Toronto researcher Dr. Andrew Fraser, they are fascinating. "I think worms are totally cool, like humans only simpler and easier," writes Dr. Fraser on his website. In fact, working with the invertebrates is what brought Dr. Fraser to the AAAS conference in San Diego, California where he presented some of his research findings in a symposium called "The Impact of Genomics." What the NSERC-funded...

2010-02-11 12:51:00

NEW YORK, Feb. 11 /PRNewswire-USNewswire/ -- The Alzheimer's Foundation of America (AFA) today applauded the Social Security Administration for including early-onset Alzheimer's disease among the medical conditions that will be given automatic approval for disability benefits, rather than have individuals go through what could be a lengthy qualification process. "Every minute counts for people with Alzheimer's disease," said Eric J. Hall, AFA's president and chief executive officer. "By...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related